Auris Medical's AM-111 drug candidate has been granted fast-track designation by the FDA. The drug which is developed for the treatment of acute sudden hearing loss is currently in phase-III trials. The intratympanic therapy is being investigated in ...
10 people with Sudden Hearing Loss have taken the SF36 survey. Mean of Sudden Hearing Loss is 2091 points (58 %). Total score ranges from 0 to 3,600 being 0 the worst and 3,600 the best. Take the SF36 Survey
